This article written in french by Nicholas Pereira was automatically translated using AI
Health Canada has issued a notice regarding a batch of NRA-Amlodipine 5 mg tablets from Nora Pharma that may contain the wrong medication.
The affected bottles are from lot EM240229, with an expiry date of August 2027.
Typically, NRA-Amlodipine 5 mg tablets are white or off-white and octagonal in shape. If the bottle contains round tablets that do not match this description, they may actually be 12.5 mg extended-release metoprolol succinate tablets.
In such cases, the tablets should not be taken, and a healthcare professional should be contacted to replace the bottle. If the prescribed individual has taken the wrong medication and experiences dizziness, abnormally low blood pressure, or a slowed heart rate, they should call 911.
NRA-Amlodipine is used to treat high blood pressure and chest pain in adults and children aged 6 to 17 years.
Extended-release 12.5 mg metoprolol succinate tablets are also used to treat high blood pressure and chest pain, but substituting amlodipine (5 mg) with metoprolol (12.5 mg) can lead to serious side effects.
These may include dangerous fluctuations in blood pressure—especially dangerously low drops—breathing difficulties, or an abnormally slow heart rate.
Patients with other conditions, particularly heart failure, asthma, severe peripheral arterial disease, pheochromocytoma, or diabetes, and those taking other medications may experience different and potentially more severe side effects.
Children who take the wrong medication may also face a higher risk of serious adverse effects and potential harm.
Health Canada notes that it is monitoring the recall and the company’s investigation, including the implementation of corrective and preventive measures to avoid recurrence. (N.P.)
Simple and Free
Meta (Facebook and Instagram) is blocking your news from Courrier Laval, just as Google continues to restrict access in response to Bill C-18.
To stay connected and access your news, Courrier Laval invites you to download its app. You can also subscribe to the weekly newsletter. This way, you can continue reading your news for free and in real time, with fewer ads. Don’t forget to enable notifications and share this with your friends and contacts!
Apple: https://apple.co/3wsgmKE
Android: https://bit.ly/3uGPo1D
Newsletter: https://courrierlaval.com/infolettre/
